Customer Story
Successful research grant application: How Leica Biosystems simplified R&D funding with innoscripta
Structured & fast application process
Trusted long-term collaboration
Industry
Medical Technology (MedTech)
Company Size
Large Enterprise
Location
Nussloch, Germany
“For me, it was the perfect combination of technology and personal consultation. The application process was much simpler and faster than I had expected. Working with innoscripta was efficient yet always personal. It was a true partnership.”
Meet Leica Biosystems
Leica Biosystems is a globally leading company in anatomic pathology solutions with more than 150 years of industrial presence. Innovation is in their DNA, driving continuous progress from the creation of the microtome in 1872 to present advancements in AI-powered digital pathology. Since their establishment, the company has consistently focused on addressing evolving challenges of pathology, developing new products, structuring comprehensive workflows, building global presence, and entering a new era of science and technology.
With operations in 35 countries, a workforce consisting of more than 3,000 people, six manufacturing sites, and approximately 1,700 patents worldwide, Leica Biosystems provides a comprehensive portfolio spanning the entire workflow from biopsy to diagnosis. Their mission of advancing cancer diagnostics and improving lives reflects their deep commitment to better cancer diagnostics and enhanced quality of life. As part of the Danaher Corporation, Leica Biosystems benefits from science and technology leadership that expands their capabilities and strengthens the transformative potential to enrich billions of lives every day.
The Challenge: Uncertainty about funding opportunities
As an innovator committed to faster and more reliable diagnostics in the field of medical technology, Leica has capable projects that would qualify for government-backed funding support.
However, the research grant presented considerable uncertainty, which included:
- Do the projects meet the eligibility criteria?
- How high is the effort required to refinance the innovation costs?
- How can the complexities of the funding programme be tackled?
The Solution: The perfect combination of technology and personal consultation
Through their collaboration with innoscripta, Leica gained a new level of clarity and the direction needed to access the research allowance.
innoscripta's intuitive software Clusterix provided practical support, while experienced professionals confidently guided Leica through every stage of the process. The perfect combination of digital efficiency and personalised consultation generated a seamless experience for Leica in the process of obtaining the research grant.
The Impact: Successful research grant and a reliable partnership
The most remarkable result of this partnership was the successful research allowance for Leica’s innovative projects.With the right support in place, the research grant application process turned out to be significantly faster and easier than initial expectations. The collaboration with innoscripta is both efficient and distinctly personal for Leica.
